DNA Vaccines: Immunology, Application, and Optimization

Article Properties
  • Language
    English
  • Publication Date
    2000/04/01
  • Indian UGC (Journal)
  • Refrences
    246
  • Citations
    839
  • Sanjay Gurunathan Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892 (Corresponding author),Section of Retroviral Immunology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, Maryland, 20892;
  • Dennis M. Klinman Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892 (Corresponding author),Section of Retroviral Immunology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, Maryland, 20892;
  • Robert A. Seder Laboratory of Clinical Investigation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, 20892 (Corresponding author),Section of Retroviral Immunology, Center for Biologics Evaluation and Research, US Food and Drug Administration, Bethesda, Maryland, 20892;
Abstract
Cite
Gurunathan, Sanjay, et al. “DNA Vaccines: Immunology, Application, and Optimization”. Annual Review of Immunology, vol. 18, no. 1, 2000, pp. 927-74, https://doi.org/10.1146/annurev.immunol.18.1.927.
Gurunathan, S., Klinman, D. M., & Seder, R. A. (2000). DNA Vaccines: Immunology, Application, and Optimization. Annual Review of Immunology, 18(1), 927-974. https://doi.org/10.1146/annurev.immunol.18.1.927
Gurunathan S, Klinman DM, Seder RA. DNA Vaccines: Immunology, Application, and Optimization. Annual Review of Immunology. 2000;18(1):927-74.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Immunologic diseases
Allergy
Description

Unlock the potential of DNA vaccines! This review examines the immunological mechanisms, applications, and optimization strategies for DNA vaccines, a promising approach to elicit both humoral and cellular immune responses. Traditional vaccines primarily induce antibody responses, but intracellular pathogens require cell-mediated immunity. DNA vaccines, containing the gene for the antigen of interest, can generate both types of immune responses. This review elucidates the mechanisms by which DNA vaccines elicit these responses. It provides an overview of potential applications in preclinical models, ranging from infectious diseases to cancer. DNA vaccines offer a versatile platform for vaccination, particularly against intracellular pathogens. By focusing on the mechanisms of immune response and strategies for optimization, this review provides valuable insights for researchers and clinicians in the field. Further development and refinement of DNA vaccine technology hold promise for addressing unmet medical needs.

Published in the Annual Review of Immunology, this review fits directly within the journal's scope by providing an in-depth examination of DNA vaccines and their immunological mechanisms. By covering the application and optimization of this technology, the article provides valuable insights for immunologists and vaccine researchers. This aligns with the journal's mission to present comprehensive reviews of cutting-edge topics in immunology.

Refrences
Citations
Citations Analysis
The first research to cite this article was titled Innate immunity—beginning to fulfill its promise? and was published in 2000. The most recent citation comes from a 2024 study titled Innate immunity—beginning to fulfill its promise? . This article reached its peak citation in 2004 , with 72 citations.It has been cited in 323 different journals, 16% of which are open access. Among related journals, the Vaccine cited this research the most, with 123 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year